ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.405,64
-1,10%
S&P 500
5.260,94
-0,43%
Dow Jones
38.508,48
-0,16%
Euro vs US Dollar
1,08782
-0,26%
Bitcoin
70.995,25
3,18%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. AMEX
  6. China Pharma Holdings Inc (CPHI)

  7. China Pharma Holdings Inc (CPHI) News

CPHI

China Pharma (CPHI)

China Pharma Holdings Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:AMEX:CPHI
DatumZeitQuelleÜberschriftSymbolFirma
30/05/202422h05Edgar (US Regulatory)Form 8-K - Current reportAMEX:CPHIChina Pharma Holdings Inc
15/05/202422h06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:CPHIChina Pharma Holdings Inc
08/05/202422h05Edgar (US Regulatory)Form 8-K - Current reportAMEX:CPHIChina Pharma Holdings Inc
23/02/202422h05Edgar (US Regulatory)Form 8-K - Current reportAMEX:CPHIChina Pharma Holdings Inc
23/02/202422h05PR Newswire (US)China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock SplitAMEX:CPHIChina Pharma Holdings Inc
15/02/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:CPHIChina Pharma Holdings Inc
08/02/202422h05Edgar (US Regulatory)Form 8-K - Current reportAMEX:CPHIChina Pharma Holdings Inc
06/02/202422h16Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]AMEX:CPHIChina Pharma Holdings Inc
26/01/202423h04Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsAMEX:CPHIChina Pharma Holdings Inc
26/01/202423h04Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:CPHIChina Pharma Holdings Inc
12/01/202422h05Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933AMEX:CPHIChina Pharma Holdings Inc
12/01/202420h42Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]AMEX:CPHIChina Pharma Holdings Inc
21/12/202322h05Edgar (US Regulatory)Form 8-K - Current reportAMEX:CPHIChina Pharma Holdings Inc
19/12/202322h05Edgar (US Regulatory)Form 8-K - Current reportAMEX:CPHIChina Pharma Holdings Inc
29/11/202314h00PR Newswire (US)China Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic DeviceAMEX:CPHIChina Pharma Holdings Inc
13/11/202322h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:CPHIChina Pharma Holdings Inc
07/11/202322h05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:CPHIChina Pharma Holdings Inc
27/10/202322h06Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsAMEX:CPHIChina Pharma Holdings Inc
19/10/202322h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CPHIChina Pharma Holdings Inc
03/10/202322h05Edgar (US Regulatory)Form 8-K - Current reportAMEX:CPHIChina Pharma Holdings Inc
14/08/202321h40Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:CPHIChina Pharma Holdings Inc
09/08/202314h30PR Newswire (US)China Pharma's Candesartan Hypertension Product Passes the Quality and Efficacy Consistency Evaluation of Generic DrugsAMEX:CPHIChina Pharma Holdings Inc
12/05/202322h07Edgar (US Regulatory)Quarterly Report (10-q)AMEX:CPHIChina Pharma Holdings Inc
30/03/202322h56Edgar (US Regulatory)Annual Report (10-k)AMEX:CPHIChina Pharma Holdings Inc
29/03/202322h06Edgar (US Regulatory)Current Report Filing (8-k)AMEX:CPHIChina Pharma Holdings Inc
09/03/202322h07Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:CPHIChina Pharma Holdings Inc
09/03/202322h06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:CPHIChina Pharma Holdings Inc
24/02/202322h07Edgar (US Regulatory)Current Report Filing (8-k)AMEX:CPHIChina Pharma Holdings Inc
24/02/202322h05PR Newswire (US)China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock SplitAMEX:CPHIChina Pharma Holdings Inc
30/12/202222h06Edgar (US Regulatory)Current Report Filing (8-k)AMEX:CPHIChina Pharma Holdings Inc
 Showing the most relevant articles for your search:AMEX:CPHI

Kürzlich von Ihnen besucht

TSX
TQGM
TD Q Global Multifactor ...
BIT
I09334
Intesa Sanpaolo
BIT
ALA
Ala
NYSE
SHO-D.CL
BIT
UB60HY
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten